Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Autism Spectrum Disorder (ASD) and Intellectual Disability (ID) Determinants in Tuberous Sclerosis Complex (TSC)

NCT02461459 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.

NCT NCT02461459
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02461459 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Autism Spectrum Disorder (ASD) and Intellectual Disability (ID) Determinants in Tuberous Sclerosis Complex (TSC)
Lead sponsor
Boston Children's Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
May 31, 2015
Completion date
December 31, 2026
Enrollment
205 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

autism disorder, intellectual disability, tuberous sclerosis